GSK-203167

Study Sponsor: GSK

Study Title

A multicentre, randomised, double-blind (sponsor-unblinded), placebo-controlled, repeat dose study to investigate the safety and tolerability, pharmacokinetics, pharmacodynamics, and efficacy of GSK2982772 in subjects with active plaque-type psoriasis

Medicine or Vaccine (generic name)

GSK2982772

Sponsor Identification Number

203167

Trial Registry Identification Number(#'s)

NCT02776033

Medical Condition

Psoriasis

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=203167

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02776033

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

May 2020